Kristen Riemenschneider and Vinita Kailasanath | Source | Partners, Life Sciences at Freshfields Bruckhaus Deringer

Kristen Riemenschneider represents life sciences companies on their most significant transactions, from strategic license and collaboration transactions to complex supply chain arrangements. She has a deep technical understanding of the life sciences industry, and has negotiated agreements in respect of cutting-edge technologies including gene editing and cell therapies.

Vinita Kailasanath has extensive experience in strategic intellectual property and data-driven transactions in life sciences and technology, and particularly at their intersection. She has represented life sciences companies, technology companies, healthcare companies and providers, and investors in connection with the execution of their cutting-edge MedTech and digital health strategies in addition to their other complex licenses and collaborations, strategic investments, and R&D and supply agreements.